<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">93862</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Nikotinzamestitel'naya terapiya v lechenii tabachnoy zavisimosti u patsientov s serdechno-sosudistymi zabolevaniyami</article-title><trans-title-group xml:lang="ru"><trans-title>Никотинзаместительная терапия в лечении табачной зависимости у пациентов с сердечно-сосудистыми заболеваниями</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gambaryan</surname><given-names>M. G</given-names></name><name xml:lang="ru"><surname>Гамбарян</surname><given-names>М. Г</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">ФГБУ Государственный научно-исследовательский центр профилактической медицины Минздрава РФ, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-05-15" publication-format="electronic"><day>15</day><month>05</month><year>2013</year></pub-date><volume>15</volume><issue>5</issue><issue-title xml:lang="en">VOL 15, NO5 (2013)</issue-title><issue-title xml:lang="ru">ТОМ 15, №5 (2013)</issue-title><fpage>51</fpage><lpage>56</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2013, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2013, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/93862">https://consilium.orscience.ru/2075-1753/article/view/93862</self-uri><abstract xml:lang="ru"><p>В современной медицине табакокурение рассматривается как вариант токсикомании. В Международной классификации болезней 10-го пересмотра табачная зависимость классифицируется как самостоятельная нозологическая единица – «психические и поведенческие расстройства, вызванные употреблением табака» [8]. Ведущими признаками расстройств, вызванных психоактивными веществами, являются: 1) потребность в повторных приемах препарата, развитие абстинентного синдрома, т.е. возникновение психических и физических расстройств при элиминации токсического вещества – никотина, 2) изменение толерантности и развитие зависимости – появление потребности больших доз психоактивного вещества и 3) способность вызывать функциональные и органические поражения внутренних органов и нервной системы. Поэтому подавляющее большинство курильщиков страдают табачной зависимостью и нуждаются в адекватной медицинской помощи.Потребление табака – главный модифицируемый фактор риска основных хронических неинфекционных заболеваний, таких как сердечно-сосудистые заболевания (ССЗ), хроническая обструктивная болезнь легких (ХОБЛ), злокачественные новообразования и другие неинфекционные заболевания, обусловливающих 82% смертности населения в РФ.</p></abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Lopez A. Smoking and death in Russia. Tobacco Control 1998; 7: 3–4.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>World Health Organization – NCD Country Profiles, 2011. http://www.who.int/nmh/countries/rus_en.pdf</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 115: 242–9.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Шальнова С.А., Деев А.Д., Оганов Р.Г. Факторы, влияющие на смертность от сердечно - сосудистых заболеваний в российской популяции. Кардиоваск. терапия и профилактика. 2005; 4 (1): 4–9.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rivers J.T, White H.D, Cross D.B et al. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: Incidence and effect of smoking. J Am Coll Cardiol 1990; 16; 340–8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Balfour D, Benowitz N, Fagerstrom K et al. Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. European Heart J 2000; 21: 438–45.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Iestra J.A et al. A systematic review. Circulation 2005; 112: 924–34.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Международная классификация болезней МКБ-10. Класс: психические расстройства и расстройства поведения. Блок: психические расстройства и расстройства поведения, связанные с употреблением психоактивных веществ. http://www.mkb10.ru/?class=5&amp;bloc=65</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Региональное бюро ВОЗ. Глобальный опрос взрослого населения о потреблении табака. РФ, 2009.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Giovino G.A, Henningfield J.E, Tomar S.L et al. Epidemiology of tobacco use and dependence. Epidem Rev 1995; 17: 48–65.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hughes J.R, Gulliver S.B, Fenwick J.W et al. Smoking cessation among self - quitters. Health Psychol 1992; 11: 331–4.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rigotti N.A, Singer D.E, Mulley A.G. Jr, Thibault G.E. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 1991; 6: 305–11.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Jimenez-Ruiz C.A, Masa F, Miravitlles M et al. Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest 2001; 119: 1365–70.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Walters N, Coleman T. Comparison of the smoking behaviour and attitudes of smokers who attribute respiratory symptoms to smoking with those who do not. Br J Gen Pract 2002; 52: 132–4.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Benowitz N.L. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med Vol. 2008; 121 (4): 3–10.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Dani J.A, De Biasi M. Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 2001; 70: 439–46.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Nestler E.J. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8: 1445–9.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Benowitz N.L. Nicotine addiction. Prim Care 1999; 26: 611–31.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Wang H, Sun X. Desensitized nicotinic receptors in brain. Brain Res Brain Res Rev 2005; 48: 420–37.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Dani J.A, Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996; 16: 905–8.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Brody A.L, Mandelkern M.A, London E.D et al. Cigarette smoking saturates brain a4b2 nicotinic acetylcholine receptors. Arch Gen Psychiat 2006; 63: 907–15.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Hughes J.R. Clinical significance of tobacco with drawal. Nicotine Tob Res 2006; 8: 153–6.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Tran K, Asakawa K, Cimon K et al. Pharmacologic - based strategies for smoking cessation: clinical and cost - effectiveness analyses. V. 2 (3). Cadth Technol Overv 2012; PMC 34426192010.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Henningfield J.E. Nicotine medications for smoking cessation. N Engl J Med 1995; 333: 1196–203.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Treating tobacco use and dependence: 2008 update. Tobacco use and dependence guideline panel. Rockville (MD): US Department of Health and Human Services 2008.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Stead L.F, Perera R, Bullen C et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012; 14: 11. CD000146. doi: 10.1002/14651858. CD000146.pub4</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Tonnesen R, Paoletti P, Gustavsson G et al. Higher dosage nicotine patches increase one - year smoking cessation rates: results from the European CEASE trial. Eur Resp J 1999; 13: 238–46.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Molyneux A, Lewis S, Leivers U et al. Clinical trial comparing nicotine replacement therapy (NRT) plus brief counselling, brief counselling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax 2003; 58 (6): 484–8.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Treating tobacco use and dependence: 2008 update. Tobacco use and dependence guideline panel. Rockville (MD): US Department of Health and Human Services 2008.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Mills E.J, Wu P, Lockhart I et al. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta - analysis of one hundred and twenty studies involving 177,390 individuals. Tobacco Induced Diseas 2010; 8 (8). http://www.tobaccoinduceddiseases.com/content/8/1/8</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Ottervanger J.P, Festen J.M, Vries de A.G, Stricker B.H. Acute myocardial infarction while using the nicotine patch. Chest 1995; 107: 1765–6.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Ropchan G.V, Sanfilippo A.J, Ford S.E. Aortic dissection and use of the nicotine patch: a case involving a temporal relationship. Can J Cardiol 1997; 13: 525–8.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Van der Klauw M.M, Van Hillo B, Van den Berg W.H et al. Vasculitis attributed to the nicotine patch (Nicotinell). Br J Dermatol 1996; 134: 361–4.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Dacosta A, Guy J.M, Tardy B et al. Myocardial infarction and nicotine patch: a contributing or causative factor? Eur Heart J 1993; 14: 1709–11.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Pierce J.R Jr. Stroke following application of a nicotine patch [letter]. Ann Pharmacother 1994; 28: 402.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Warner J.G Jr, Little W.C. Myocardial infarction in a patient who smoked while wearing a nicotine patch [letter]. Ann Intern Med 1994; 120: 695.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Riche G, Nighoghossian N, Trouillas P. Intracerebral haematoma after application of nicotine patch [letter]. Lancet 1995; 346: 777–8.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Mathew T.P, Herity N.A. Acute myocardial infarction soon after nicotine replacement therapy [letter]. QJM 2001; 94: 503–4.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Ford C.L, Zlabek J.A. Nicotine replacement therapy and cardiovascular disease mayo. Clin Proc 2005; 80 (5): 652–6.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Working group for the study of transdermal nicotine in patients with coronary artery disease. Nicotine replacement therapy for patients with coronary artery disease. Arch Intern Med 1994; 154: 989–95.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Joseph A.M, Norman S.M, Ferry L.H et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996; 335: 1792–8.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Greenland S, Satterfield M.H, Lanes S.F. A meta - analysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf 1998; 18: 297–308.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Kimmel S.E, Berlin J.A, Miles C et al. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol 2001; 37: 1297–302.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Antman E.M, Anbe D.T, Armstrong P.W et al. ACC/AHA guidelines for the management of patients with ST - elevation myocardial infarction – executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44: 671–719.</mixed-citation></ref></ref-list></back></article>
